Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1:50 |
Assay dependent |
Assay dependent |
Not tested in other applications.
Product Note
Binds to intact whole C. botulinum Toxin A, amino acids 1280-1292. Has been found to stain Neuro2A cellstreated with GT1b ganglioside prior to the addition of C. botulinum Toxin A. Inhibits the entry of C. botulinumToxin A to Neuro2A cells treated with GT1b ganglioside prior to the addition of the toxin.Cross-Reactivity:C. botulinum Toxin A (1280-1292) 100% C. botulinum Toxin A 100% C. botulinum Toxin B 0% C. botulinum Toxin C 0% C. botulinum Toxin E 0% C. botulinum Toxin F (1272-1280) 0%
Form
Liquid
Buffer
Tissue culture supernatant
Preservative
No preservative
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Antigen Species
Clostridium botulinum
Immunogen
Synthetic peptide analogue of the carboxyl terminal region of C. botulinum Toxin A
Purification
Unpurified
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.